Senator Collins’ Bipartisan Bill to Fight Alzheimer’s to be Signed into Law

Approximately 5.5 million Americans—and 28,000 Mainers—are currently living with this disease

Washington, D.C. – Today, the U.S. House of Representatives passed the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act, legislation authored by U.S. Senators Susan Collins (R-ME), Catherine Cortez Masto (D-NV), Shelley Moore Capito (R-WV), and Tim Kaine (D-VA).  This bipartisan bill would, for the first time, create a public health infrastructure across the country to combat Alzheimer’s disease and preserve brain health.  The BOLD Act has already passed the Senate unanimously and now awaits the President’s signature.

“Alzheimer’s disease is one of the greatest and most under-recognized public health threats of our time.  Millions of Americans and thousands of Mainers are living with the disease, and that number is soaring as our overall population grows older and lives longer,” said Senator Collins, a founder and Senate co-chair of the Congressional Task Force on Alzheimer’s Disease.  “After decades of increasing investments in biomedical research for Alzheimer’s, we are ready for the next step: to translate research into practice.  The BOLD Act takes a multi-pronged public health approach that will create a modern infrastructure for the prevention, treatment, and care of Alzheimer’s and related dementias.  I am proud of the overwhelming bipartisan support our legislation received in Congress and in communities across the nation.  BOLD brings us to the brink of a brighter day for Alzheimer’s, and I look forward to it being signed into law.”

“At The Jackson Laboratory we are committed to helping to find treatments and even stop Alzheimer’s before it starts.  We’re incredibly grateful for Senator Collins’ leadership, which provides hope for the future. The new BOLD Infrastructure for Alzheimer’s Act will help to propel Alzheimer’s and dementia into the forefront as a public health issue and enable further funding to accelerate research and development for this devastating disease,” said Edison T. Liu, president & CEO, The Jackson Laboratory.

Approximately 5.5 million Americans—and 28,000 Mainers—are living with Alzheimer’s, and the disease costs the United States more than $277 billion per year, including $186 billion in costs to Medicare and Medicaid. Without further action, the number of Americans with Alzheimer’s is expected to triple to as many as 14 million by 2050, costing the nation more than $1.1 trillion per year. 

This legislation would apply a public health approach to reduce risk, detect early symptoms, advance care, improve data, and ultimately change the trajectory of this devastating disease. Headed by the Centers for Disease and Prevention (CDC), it would authorize $20 million annually over the next five years to establish:

1. Alzheimer’s Disease and Related Dementias Public Health Centers of Excellence dedicated to promoting effective Alzheimer’s disease and caregiving interventions as well as educating the public on Alzheimer’s disease, cognitive decline, and brain health.  The centers would implement the CDC’s Healthy Aging Public Health Road Map, and would take key steps to support health and social services professionals as well as families and communities.

1. Cooperative Agreements with the CDC that would be awarded to State Health Departments to help them meet local needs in promoting brain health, reducing risk of cognitive decline, improving care for those with Alzheimer’s, and other key public health activities.  

1. Data Grants to improve the analysis and timely reporting of data on Alzheimer’s, cognitive decline, caregiving, and health disparities at the state and national levels.

The BOLD Act was introduced by Senators Collins, Cortez Masto, Capito, and Kaine last year and is cosponsored by a total of 58 Senators and supported by 181 organizations and individuals, including the Alzheimer’s Association, Alzheimer’s Impact Movement, and Maria Shriver, founder of The Women’s Alzheimer’s Movement. 

Representatives Brett Guthrie (R-KY) and Paul Tonko (D-NY) introduced a companion bill in the House of Representatives, which is cosponsored by 254 members.